Life after GLP-1s: How to sustain weight loss
It should come as no surprise that GLP-1 receptor agonists have revolutionized the management of obesity and metabolic syndrome. These drugs have shown extraordinary promise in regulating appetite, promoting weight loss, and improving blood sugar control. Nearly one in eight adults (twelve percent) have taken a GLP-1 agonist, and forty-three percent of adults diagnosed with diabetes have used these therapies, numbers likely to have increased further in the last year …



![Stopping medication requires as much skill as starting it [PODCAST]](https://kevinmd.com/wp-content/uploads/The-Podcast-by-KevinMD-WideScreen-3000-px-4-190x100.jpg)
![Weaponizing food allergies in entertainment endangers lives [PODCAST]](https://kevinmd.com/wp-content/uploads/The-Podcast-by-KevinMD-WideScreen-3000-px-3-190x100.jpg)






![AI censorship threatens the lifeline of caregiver support [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-2-190x100.jpg)